Press Release

Zephyr AI Announces $111 Million Series A

March 13, 2024

Palo Alto – March 13, 2024 – Cooley advised Zephyr AI, a healthcare technology company committed to developing fast and explainable artificial intelligence solutions to democratize precision medicine, on its $111 million Series A financing. Partner Josh Seidenfeld led the Cooley team advising Zephyr AI.

The financing includes participation from Revolution Growth, Eli Lilly, Jeff Skoll and EPIQ Capital, among others. The proceeds will enable Zephyr to further enhance its analytical speed, fortify its extensive collection of training and validation data sets, and support the expansion of its scientific and commercial teams to expedite the delivery of its rapidly growing pipeline of insights to the market.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.